SCHEMBL5178012

SCHEMBL5178012

COC(=O)c1cc(Cl)cc(NS(C)(=O)=O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.60
ALDH1A1 P00352 6/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
HPGD P15428 4/20 0.55
HTT P42858 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
MAPT P10636 2/20 0.55
XBP1 P17861 1/20 0.55
KDM4E B2RXH2 3/20 0.48
HSD17B10 Q99714 1/20 0.48
FABP4 P15090 1/20 0.43
ATM Q13315 1/20 0.43
RECQL P46063 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL475593 0.88 POLB (0.70) POLBALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL5178749 0.83 WDR5 (0.54) POLBALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL1120814 0.83 ALDH1A1 (0.58) POLBALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL9071822 0.82 POLB (0.62) POLBALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL710319 0.81 POLB (0.60) POLBALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL28543927 0.80 KDM4E (0.59) ALDH1A1SMN1; SMN2HPGDHTTMEN1
SCHEMBL12852694 0.80 MAPT (0.61) POLBALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL24102922 0.79 TCF4 (0.68) ALDH1A1SMN1; SMN2HPGDHTTMEN1
SCHEMBL588343 0.78 ALDH1A1 (0.62) POLBALDH1A1SMN1; SMN2HPGDHTT
SCHEMBL67540 0.78 ALDH1A1 (0.62) POLBALDH1A1SMN1; SMN2HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1791810-A1 4-AMINOMETHYL BENZAMIDINE DERIVATIVES AND THEIR USE AS FACTOR VIIA INHIBITORS F. Hoffmann-Roche AG (CH) 2007-06-06 EP disclosed
US-20060116410-A1 4-Aminomethyl benzamidine derivatives HOFFMANN-LA ROCHE INC. 2006-06-01 US disclosed
WO-2006027135-A1 4-AMINOMETHYL BENZAMIDINE DERIVATIVES AND THEIR USE AS FACTOR VIIIA INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116410-A1 4-Aminomethyl benzamidine derivatives F7, HABP2, F12 POLB 4510/4885ALDH1A1 965/4885SMN1; SMN2 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.